The Venture Codex Logo

The Venture Codex

Overview

Venture capital fund financing biotech and life science projects.

Founded

2017

Deals · 12mo

1

Stage focus

Series A
Series B

Geographic focus

Belgium
France
Switzerland

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

10rounds
NAMEDATESIZE
Bioxodes
Dec 2025Led
$6 MSeries A
Augustine Therapeutics
Mar 2025Participated
$91 MSeries A
AbolerIS Pharma
Sep 2023Participated
$29 MSeries A
Santero Therapeutics
Jun 2023Led
$9 MSeries A
DeuterOncology
Jan 2023Led
$6 MSeries A
Synergia Medical
Jan 2023Participated
$4 MSeries B
Acticor Biotech
Nov 2019Participated
$8 MSeries B
Acticor Biotech
Oct 2018Led
$18 MSeries B
Sequana Medical
Oct 2018Participated
$10 MOther Equity
Synergia Medical
Feb 2018Led
$10 MSeries A
Bioxodes
Dec 2025Led
$6 MSeries A
Augustine Therapeutics
Mar 2025Participated
$91 MSeries A
AbolerIS Pharma
Sep 2023Participated
$29 MSeries A
Santero Therapeutics
Jun 2023Led
$9 MSeries A
DeuterOncology
Jan 2023Led
$6 MSeries A
Synergia Medical
Jan 2023Participated
$4 MSeries B
Acticor Biotech
Nov 2019Participated
$8 MSeries B
Acticor Biotech
Oct 2018Led
$18 MSeries B
Sequana Medical
Oct 2018Participated
$10 MOther Equity
Synergia Medical
Feb 2018Led
$10 MSeries A
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Newton Biocapital: 10 funding rounds are recorded in the selected participation categories.All available history.
Newton Biocapital: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A42
Series B12
Other Equity01

Monthly Deal Activity

Newton Biocapital: 10 deals are recorded across 105 months.All available history.
Newton Biocapital: 10 deals are recorded across 105 months. All available history
MonthDeals
Feb '181
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '182
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '232
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Newton Biocapital: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Newton Biocapital: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
Enterprise Software2
Manufacturing1

Deal Size Distribution

Newton Biocapital: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Newton Biocapital: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M5
$10M-$25M2
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Newton Biocapital: Europe has the largest recorded deal count among the displayed regions (10 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Newton Biocapital: Europe has the largest recorded deal count among the displayed regions (10 deals). All available history
RegionDeals
Europe10
Newton Biocapital: 20 co-investors are shown, with SFPI-FPIM sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Newton Biocapital: Led accounts for 50% and participating for 50% of round participation.All available history.
Newton Biocapital: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led550%
Participating550%
Newton Biocapital: Single-lead accounts for 80% and co-led for 20% of lead dynamics.All available history.
Newton Biocapital: Single-lead accounts for 80% and co-led for 20% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead480%
Co-led120%

Team

Alain Parthoens

Managing Partner and Founder

Goro Takeda

Managing Partner

Toshiyuki Mori

Partner, Tokyo